Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| azithromycin,[CFS] |
📓
Shuanghuanglian oral preparations combined with azithromycin for treatment of Mycoplasma pneumoniae pneumonia in Asian children: A systematic review and meta-analysis of randomized controlled trials. PloS one (PLoS One ) Vol: 16 Issue 7 Pages: e0254405 Pub: 2021 Epub: 2021 Jul 13 Authors Peng Y , Chen Z , Li Y , Lu Q , Li H , Han Y , Sun D , Li X , Html Article Publication |
| azithromycin,[CFS] |
👪
Shuanghuanglian oral preparations combined with azithromycin for treatment of Mycoplasma pneumoniae pneumonia in Asian children: A systematic review and meta-analysis of randomized controlled trials. PloS one (PLoS One ) Vol: 16 Issue 7 Pages: e0254405 Pub: 2021 Epub: 2021 Jul 13 Authors Peng Y , Chen Z , Li Y , Lu Q , Li H , Han Y , Sun D , Li X , Html Article Publication |
| azithromycin,[CFS] |
👪
Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use. The Journal of infectious diseases (J Infect Dis ) Vol: 219 Issue 4 Pages: 619-623 Pub: 2019 Jan 29 Epub: Authors Olesen SW , Torrone EA , Papp JR , Kirkcaldy RD , Lipsitch M , Grad YH , Html Article Publication |
| azithromycin,[CFS] |
📓
Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use. The Journal of infectious diseases (J Infect Dis ) Vol: 219 Issue 4 Pages: 619-623 Pub: 2019 Jan 29 Epub: Authors Olesen SW , Torrone EA , Papp JR , Kirkcaldy RD , Lipsitch M , Grad YH , Html Article Publication |
| azithromycin,[CFS] |
👶
Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use. The Journal of infectious diseases (J Infect Dis ) Vol: 219 Issue 4 Pages: 619-623 Pub: 2019 Jan 29 Epub: Authors Olesen SW , Torrone EA , Papp JR , Kirkcaldy RD , Lipsitch M , Grad YH , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
